News - Page 168 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psychedelic Bulletin: Ex-FDA Psychiatry Director Joins Cybin as Advisor; Texas Approves Psychedelics Studies; and more…

Psychedelic Bulletin: Ex-FDA Psychiatry Director Joins Cybin as Advisor; Texas Approves Psychedelics Studies; and more…

Post published:June 25, 2021
Post category:Psychedelic Bulletin

Read more about the article UK Set to Become Hub of Psychedelic Research, as British Startup Gears-up to Run Trials for International Psychedelic Drug Developers

UK Set to Become Hub of Psychedelic Research, as British Startup Gears-up to Run Trials for International Psychedelic Drug Developers

Post published:June 25, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

Post published:June 24, 2021
Post category:Press Release

Read more about the article Wesana Health Partners with University of South Carolina

Wesana Health Partners with University of South Carolina

Post published:June 24, 2021
Post category:Press Release

Read more about the article Albert Labs Announces a Distinguished Clinical and Scientific Advisory Board

Albert Labs Announces a Distinguished Clinical and Scientific Advisory Board

Post published:June 24, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer

Post published:June 24, 2021
Post category:Press Release

Read more about the article Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board

Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board

Post published:June 24, 2021
Post category:Press Release

Read more about the article Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

Post published:June 24, 2021
Post category:Press Release

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species

Post published:June 24, 2021
Post category:Press Release

Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic Mushroom Brand, in Collaboration with the Bob Marley Family

Post published:June 24, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.